1. World Health Organization. Pharmacovigilance: ensuring the safe use of medicines. World Health Organization; 2004. https://apps.who.int/iris/handle/10665/68782. (Accessed: 7th April 2023)
2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. The Lancet. 2000;356(9237):1255–9. https://doi.org/10.1016/S0140-6736(00)02799-9.
3. World Health Organization. Quality Assurance and Safety of Medicines Team. Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. World Health Organization; 2002. https://apps.who.int/iris/handle/10665/67378 Accessed: 7th April 2023)
4. World Health Organization. The Uppsala monitoring system, WHO Collaborating Centre for International Drug Monitoring. World Health Organization; 2002. p. 28–34. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/health-professionals-info/collaborative-centers
5. Bride W. Thalidomide and congenital malformations. Lancet. 1961;1:358. https://www.jameslindlibrary.org/mcbride-wg-1961/